Millennium Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.71M Buy
4,944,731
+122,998
+3% +$179K 0.01% 2442
2025
Q4
$5.54M Buy
4,821,733
+991,073
+26% +$1.36M ﹤0.01% 2892
2025
Q3
$5.17M Buy
3,830,660
+2,187,396
+133% +$2.48M ﹤0.01% 3120
2025
Q2
$1.55M Buy
+1,643,264
New +$1.06M ﹤0.01% 4089
2025
Q1
Hold
0
6265
2024
Q4
Sell
-1,398,876
Closed -$2.2M 6320
2024
Q3
$2.2M Buy
1,398,876
+801,555
+134% +$1.43M ﹤0.01% 3623
2024
Q2
$1M Buy
597,321
+63,137
+12% +$113K ﹤0.01% 4107
2024
Q1
$1.28M Sell
534,184
-1,098,992
-67% -$2.36M ﹤0.01% 4090
2023
Q4
$2.5M Sell
1,633,176
-2,252,577
-58% -$2.68M ﹤0.01% 3420
2023
Q3
$4.24M Buy
3,885,753
+1,251,580
+48% +$2.2M ﹤0.01% 2845
2023
Q2
$6.03M Buy
2,634,173
+2,610,329
+10,948% +$6.93M 0.01% 2488
2023
Q1
$58K Sell
23,844
-1,152,723
-98% -$2.64M ﹤0.01% 5576
2022
Q4
$2.25M Buy
1,176,567
+270,656
+30% +$576K ﹤0.01% 3477
2022
Q3
$2.17M Buy
905,911
+687,963
+316% +$1.9M ﹤0.01% 3669
2022
Q2
$405K Sell
217,948
-150,706
-41% -$288K ﹤0.01% 5121
2022
Q1
$770K Buy
368,654
+113,516
+44% +$315K ﹤0.01% 4769
2021
Q4
$1M Buy
255,138
+177,101
+227% +$860K ﹤0.01% 4404
2021
Q3
$375K Sell
78,037
-101,818
-57% -$418K ﹤0.01% 5627
2021
Q2
$826K Sell
179,855
-3,832
-2% -$18.5K ﹤0.01% 4849
2021
Q1
$1.08M Sell
183,687
-744,486
-80% -$5.16M ﹤0.01% 4146
2020
Q4
$3.17M Buy
928,173
+799,255
+620% +$1.52M ﹤0.01% 2860
2020
Q3
$186 Buy
+128,918
New +$230K ﹤0.01% 4088
2020
Q1
Sell
-1,309,722
Closed -$5.43M 4233
2019
Q4
$5.43M Buy
1,309,722
+89,093
+7% +$343K 0.01% 1859
2019
Q3
$3.67M Buy
1,220,629
+1,184,819
+3,309% +$3.67M 0.01% 2032
2019
Q2
$225K Sell
35,810
-7,798
-18% -$46.7K ﹤0.01% 3698
2019
Q1
$242K Sell
43,608
-51,561
-54% -$313K ﹤0.01% 3651
2018
Q4
$632K Buy
95,169
+11,862
+14% +$96.1K ﹤0.01% 2817
2018
Q3
$889K Sell
83,307
-346,046
-81% -$3.97M ﹤0.01% 2940
2018
Q2
$5.15M Buy
+429,353
New +$4.39M 0.01% 1798
2018
Q1
Sell
-381,266
Closed -$3.77M 3903
2017
Q4
$3.77M Sell
381,266
-2,605
-0.7% -$27.1K 0.01% 1896
2017
Q3
$4.72M Sell
383,871
-308,964
-45% -$4.56M 0.01% 1706
2017
Q2
$11.4M Buy
692,835
+507,990
+275% +$7.87M 0.02% 981
2017
Q1
$2.65M Sell
184,845
-42,007
-19% -$623K 0.01% 1836
2016
Q4
$3.14M Sell
226,852
-233,098
-51% -$3.74M 0.01% 1627
2016
Q3
$8.31M Buy
459,950
+12,751
+3% +$205K 0.02% 1035
2016
Q2
$6.42M Sell
447,199
-631,941
-59% -$8.57M 0.02% 1113
2016
Q1
$12.9M Buy
1,079,140
+228,733
+27% +$2.4M 0.04% 689
2015
Q4
$11.3M Buy
850,407
+531,026
+166% +$6.53M 0.03% 860
2015
Q3
$3.43M Buy
319,381
+235,141
+279% +$2.57M 0.01% 1559
2015
Q2
$678K Buy
84,240
+61,818
+276% +$454K ﹤0.01% 2478
2015
Q1
$148K Sell
22,422
-24,975
-53% -$171K ﹤0.01% 3353
2014
Q4
$302K Buy
+47,397
New +$382K ﹤0.01% 3348

Other funds holding LXRX